Pay in 4 interest-free payments of $27.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
InChiKey: MQMKRQLTIWPEDM-UHFFFAOYSA-N
PMID: 32152610
2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide hydrochloride
(2012) Cancer Res
4-c]carbazol-12(13H)-yl)propanenitrile
Linifanib (ABT-869) - CAS# 796967-16-3 acin(DU 6859A) InChiKey: MQMKRQLTIWPEDM-UHFFFAOYSA-NLinifanib, CAS No. 796967 16 3, also known as ABT 869, is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Linifanib inhibits members of the vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) receptor families; it exhibits much less activity against unrelated RTKs, soluble tyrosine kinases, or serine threonine kinases. This agent does not have a
US$ 30.00
US$ 540.00
US$ 280.00
US$ 74.00
US$ 21.99
US$ 185.00